Botulinum toxin A for the Treatment of Overactive Bladder

The standard treatment for overactive bladder starts with patient education and behavior therapies, followed by antimuscarinic agents. For patients with urgency urinary incontinence refractory to antimuscarinic therapy, currently both American Urological Association (AUA) and European Association of...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsieh, Po-Fan, Chiu, Hung-Chieh, Chen, Kuan-Chieh, Chang, Chao-Hsiang, Chou, Eric Chieh-Lung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4810204/
https://www.ncbi.nlm.nih.gov/pubmed/26938559
http://dx.doi.org/10.3390/toxins8030059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4810204/
https://www.ncbi.nlm.nih.gov/pubmed/26938559
http://dx.doi.org/10.3390/toxins8030059

Ejemplares similares